News articles for NPS Pharmaceuticals, Inc.:
Monday, June 17, 2013
Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company
pioneering and delivering therapies that transform the lives of patients
with rare diseases worldwide, yesterday presented findings supporting
...
read moreFriday, June 14, 2013
Wednesday, June 5, 2013
Friday, May 31, 2013
Wednesday, May 29, 2013
Tuesday, May 28, 2013
Wednesday, May 22, 2013
Tuesday, May 21, 2013
Monday, May 20, 2013
Thursday, May 16, 2013
Thursday, May 9, 2013
Wednesday, May 1, 2013
Monday, March 18, 2013
Tuesday, March 5, 2013
Thursday, February 28, 2013
Thursday, February 21, 2013
Wednesday, February 13, 2013
Tuesday, February 5, 2013
Thursday, January 3, 2013